Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.
Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on June 11, 2021, after which the MBIO stock price saw a push of 5.25% to reach $4.01 a share at the time of this writing. The last trading session was favorable […]